Evaluation of Nosocomial Infection Control Programs in health services

Menegueti, Mayra Gonçalves; Canini, Sílvia Rita Marin da Silva; Bellissimo-Rodrigues, Fernando; Laüs, Ana Maria

doi:10.1590/0104-1169.0113.2530

Cited by 36 publications

(49 citation statements)

References 11 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Training of healthcare professionals, especially nurses, is extremely important for the control and prevention of infection [2,35] . A large gap is present between the existence of guidelines and their actual implementation [36] .…”

Section: Development Of Infection Control Programsmentioning

confidence: 99%

Nosocomial infections and their control strategies

Khan

Ahmad

Mehboob

2015

Asian Pacific Journal of Tropical Biomedicine

294

218

View full text Add to dashboard Cite

A B S T R A C TNosocomial infections are also known as hospital-acquired/associated infections. National Healthcare Safety Network along with Centers for Disease Control for surveillance has classified nosocomial infection sites into 13 types with 50 infection sites, which are specific on the basis of biological and clinical criteria. The agents that are usually involved in hospital-acquired infections include Streptococcus spp., Acinetobacter spp., enterococci, Pseudomonas aeruginosa, coagulase-negative staphylococci, Staphylococcus aureus, Bacillus cereus, Legionella and Enterobacteriaceae family members, namely, Proteus mirablis, Klebsiella pneumonia, Escherichia coli, Serratia marcescens. Nosocomial pathogens can be transmitted through person to person, environment or contaminated water and food, infected individuals, contaminated healthcare personnel's skin or contact via shared items and surfaces. Mainly, multi-drug-resistant nosocomial organisms include methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, Pseudomonas aeruginosa and Klebsiella pneumonia, whereas Clostridium difficile shows natural resistance. Excessive and improper use of broad-spectrum antibiotics, especially in healthcare settings, is elevating nosocomial infections, which not only becomes a big health care problem but also causes great economic and production loss in the community. Nosocomial infections can be controlled by measuring and comparing the infection rates within healthcare settings and sticking to the best healthcare practices. Centers for Disease Control and Prevention provides the methodology for surveillance of nosocomial infections along with investigation of major outbreaks. By means of this surveillance, hospitals can devise a strategy comprising of infection control practices.

show abstract

Section: Development Of Infection Control Programsmentioning

confidence: 99%

Nosocomial infections and their control strategies

Khan

Ahmad

Mehboob

2015

Asian Pacific Journal of Tropical Biomedicine

294

218

View full text Add to dashboard Cite

show abstract

“…Нині внутрішньолікарняні інфекціївсесвітня медична, соціальна та економічна проблема (Menegueti et al, 2015;Sonmezer et al, 2016;Rezai et al, 2017). Рівень поширення внутрішньолікарняних інфекцій у країнах Європи та США в середньому становить 8,0-9,0% усіх госпіталізованих хворих.…”

Section: ключові слова: антибіотики; дезінфектанти; біоплівки; Pseudounclassified

Resistance of nosocomial strains to antibacterial drugs and its link to biofilm formation

Sklyar

Lavrentievа

Alyonkina

et al. 2017

Regul. Mech. Biosyst.

View full text Add to dashboard Cite

The problem of nosocomial infections is considered in connection with more frequent formation and wide distribution in clinical practice of new strains of hospital bacteria that have a cross-resistence to antibacterial drugs. The nosocomial agents were isolated from wounds and identified as Staphylococcus aureus and Pseudomonas aeruginosa. 72.0% of S. aureus strains and 61.5% of P. aeruginosa clinical isolates had the capability of forming biofilms. The sensitivity to antibiotics of all isolated strains was investigated with tne agar diffusion test. This method showed that all strains of S. aureus with the capability to form biofilms had resistence to erythromycin, gentamycin, ciprofloxacin and levofloxacin. The had the greatest sensitivity to klindamycin (90.3%), vancomycin (80.6%) and gatifloxacin (80.6% cultures). The strains of S. aureus with the capability to form biofilms were more resistent to antibiotics than strains of S. aureus without such properties. Only cefotaxim suppressed the growth of 75.0% of strains of staphylococci. All isolated strains of S. aureus without the capability to form biofilms were sensitive to doxycyclin, gentamycin, ciprofloxacin, levofloxacin and klindamycin. All clinical isolates of P. aeruginosa with capability to form biofilms had resistence to ampicillin, gentamycin, imipenem, cefotaxime and ceftriaxone. They were most sensitive (75.0%) to piperacillin and cefoperazone/sulbactam. The strains of P. aeruginosa without the capability to form biofilms kept the resistence to gentamycin, imipenem and ceftriaxone. They showed the greatest sensitivity (75.0%) to ciprofloxacin (80.0% isolates) and also to amikacin, ampicillin, meropenem, norfloxacin and cefotaxime (60.0% cultures). We investigated the minimum inhibitory concentrations of gentamycin and ciprofloxacin, which appeared higher for P. aeruginosa than for S. aureus. The most effective disinfectant against all isolated nosocomial agents without the capacity for biofilm formation was “Desactin” in a concentration 0.1% or 0.2%. For strains of staphylococci with this capability, the efficiency of “Desactin” went down by 9.7%. The best biocide effect against the strains of P. aeruginosa with the capability of forming biofilms was shown by 0.1% solution of “Neochlorine tabs”, which suppressed the growth of 75.0% of tested cultures. As a result, we detected a direct relationship between resistance to antibiotics and disinfectants and the capacities for biofilm formation among the nosocomial agents S. aureus and P. aeruginosa.

show abstract

“…A pesquisa de avaliação do desempenho dos PCIRAS, em estados da região Sudeste do Brasil, por meio de indicadores clínicos, tem demonstrado ser uma importante ferramenta para o conhecimento desses programas no território nacional, com vista à melhoria da qualidade da assistência prestada (5)(6)(7) . O que inquieta a conhecer como tem sido o desempenho dos PCIRAS em outras regiões brasileiras, nesse caso, na região Norte do País.…”

Section: Introductionunclassified

<b>Variáveis intervenientes no desempenho dos programas de controle e prevenção de infecção relacionada à assistência à saúde/ Intervenient variables in the performance of health care-associated infection control programs <b>

Oliveira¹,

Lacerda²

2019

Cienc. Cuid. Saúde

View full text Add to dashboard Cite

Objetivo:Avaliar as variáveis que interferem no desempenho Programas de Controle e Prevenção de Infecção Relacionada à Assistência à Saúde. Método:Estudo quantitativo de análise por estatística descritiva, em hospitais, a partir de 50 leitos. Dois instrumentos de forma utilizados na coleta de dados: O primeiro,com caracterização geral dos hospitais e dos Programas de Controle e Prevenção de Infecção Relacionada à Assistência à Saúde. O segundo,com os quatro indicadores clínicos de avaliação de Programas de Controle e Prevenção de Infecção Relacionada à Assistência à Saúde, previamente construídos e validados. Resultados: Os melhores escores foram relacionados à: entidades mantenedoras privadas; existência de algum tipo de certificação/acreditação; composição da equipe do Serviço de Controle de Infecção Hospitalar formada por enfermeiro, médico e outros (técnico de enfermagem e/ou bioquímico e/ou administrativo); vínculo empregatício institucionalizado do enfermeiro e médico;carga horária exclusiva dos enfermeiros e médicos que atuam no Serviço de Controle de Infecção Hospitalar; tempo de experiência dos enfermeiros e médicos; capacitação em controle e prevenção de Infecção Hospitalar na admissão de recursos humanos.Conclusão: Foi possível verificar as interferências das variáveis no desempenho dos programas de controle de infecção hospitalar.

show abstract

Evaluation of Nosocomial Infection Control Programs in health services

Cited by 36 publications

References 11 publications

Nosocomial infections and their control strategies

Nosocomial infections and their control strategies

Resistance of nosocomial strains to antibacterial drugs and its link to biofilm formation

<b>Variáveis intervenientes no desempenho dos programas de controle e prevenção de infecção relacionada à assistência à saúde/ Intervenient variables in the performance of health care-associated infection control programs <b>

Contact Info

Product

Resources

About